Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gerolymatos Group

Latest From Gerolymatos Group

Alapis divests non-core businesses and changes name

The rapidly developing Greek company Alapis has changed its name in line with its divestment of non-core businesses including animal health, cosmetics and liquid detergents, and medical devices. The company wants to focus on manufacturing, marketing and distribution of pharmaceutical products.


Alapis wants to expand in southeast Europe

Alapis has said that it will focus on expanding in southeast Europe after it has established itself in Greece. It wants to become one of the largest groups there and relies on the expected growth of the regional pharmaceutical market to achieve that in the next few years.

Greece Companies

Alapis's health sales grew by 25% in six months

Sales in Greek firm Alapis's health division increased by one quarter to €477.4 million and its earnings before interest, tax, depreciation and amortisation were up by 62% to €168.4 million in the first six months of this year. The company attributed the increase to the integration and consolidation of recently acquired PNG Gerolymatos and Medimec, organic sales growth of generic pharmaceutical products and expanding distribution for foreign firms.


Alapis increased turnover 2.5-fold in 2008

Greece's Alapis increased turnover more than 2.5-fold to €1.1 billion last year, to which the parent company contributed around 40% (€438.8 million; +8%). The growth mostly reflected the incorporation of the financial results of companies acquired in 2008.

Ukraine Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Greece
  • Parent & Subsidiaries
  • Gerolymatos Group
  • Senior Management
  • Panayotis Gerolymatos, Pres. & CEO
    Alberto Manouach, PhD, VP, Corp. Dev.
  • Contact Info
  • Gerolymatos Group
    Phone: (30) 210 8161107
    13 Asklipious St.
    Athens, 145 68